Skip to Content
Merck
  • Activation of the ubiquitin proteasome pathway by silk fibroin modified chitosan nanoparticles in hepatic cancer cells.

Activation of the ubiquitin proteasome pathway by silk fibroin modified chitosan nanoparticles in hepatic cancer cells.

International journal of molecular sciences (2015-01-15)
Ming-Hui Yang, Tze-Wen Chung, Yi-Shan Lu, Yi-Ling Chen, Wan-Chi Tsai, Shiang-Bin Jong, Shyng-Shiou Yuan, Pao-Chi Liao, Po-Chiao Lin, Yu-Chang Tyan
ABSTRACT

Silk fibroin (SF) is a protein with bulky hydrophobic domains and can be easily purified as sericin-free silk-based biomaterial. Silk fibroin modified chitosan nanoparticle (SF-CSNP), a biocompatible material, has been widely used as a potential drug delivery system. Our current investigation studied the bio-effects of the SF-CSNP uptake by liver cells. In this experiment, the characterizations of SF-CSNPs were measured by particle size analysis and protein assay. The average size of the SF-CSNP was 311.9 ± 10.7 nm, and the average zeta potential was +13.33 ± 0.3 mV. The SF coating on the SF-CSNP was 6.27 ± 0.17 μg/mL. Moreover, using proteomic approaches, several proteins involved in the ubiquitin proteasome pathway were identified by analysis of differential protein expressions of HepG2 cell uptake the SF-CSNP. Our experimental results have demonstrated that the SF-CSNP may be involved in liver cancer cell survival and proliferation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sodium tripolyphosphate, technical grade, 85%